psychedelic
-
Awakn Life Sciences’ Anthony Tennyson on using researched backed psychedelic drugs and therapies to treat Alcohol Use Disorder
In a recent InvestorIntel interview, Tracy Weslosky speaks with Anthony Tennyson, CEO of Awakn Life Sciences Corp. (NEO:…
-
Anthony Tennyson on Awakn Life Sciences bringing innovation in addiction treatment to the market
In a recent InvestorIntel interview, Tracy Weslosky speaks with Anthony Tennyson, CEO of Awakn Life Sciences Corp. (NEO:…
-
Newly listed Awakn Life Sciences’ team of experts prepare a pathway to treat addiction through psychedelic medicines
One of the largest problems in our society today is substance abuse and addiction. Almost 21 million Americans…
-
Mental health at the forefront of new research into Psychedelics
The liberalization of cannabis usage (pun intended) has made strides in opening up other aspects of the drug…
-
Can Psychedelics Follow Cannabis’ Lead?
Greenlight for Red Light Holland as Distribution Agreements Grow Red Light Holland Corp. (CSE: TRIP) (“RLH”) engages in the…
-
Red Light Holland’s Todd Shapiro on investing in a medical and scientific division for the understanding of medical psychedelics
“We have named a Science and Innovation division called Scarlette Lillie… We thought that this is a way…
-
Todd Shapiro of Red Light Holland on ‘magic truffles’ and the multi-billion dollar psychedelics market
“Psychedelics are a multibillion-dollar market….and that is what this industry is banking on. We are product based, we…
